Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...
Neuralink competitor Paradromics secures investment from Saudi Arabia's Neom
Paradromics announced a strategic partnership with Saudi Arabia's Neom, a developing region within the country that's touted ...
Le Lézard5h
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. , a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases ...
Biodexa Pharmaceuticals PLC: Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatmen ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
The Herald-Dispatch8h
Tibbenham Chocolate Covered Cherries: A perfectly sweet treat for Valentine’s Day
Michelle Hill has been in business since she was a teenager, and undoubtedly, her sweetest gig is owner of Tibbenham ...
christiantoday.com.au18h
God’s stamp of approval
It was Galatians chapter 1, verse 10, “Am I now trying to win the approval of human beings, or of God? Or am I trying to please people? If I were still trying to please people, I would not be a ...